Seneca Biopharma Inc fka SNCA

[BesaoT35]

We are now below $5 only 2 days after a reverse split that had us at $8+. $4.39 at this time. The market cap is now only
$4.4 million. NSI-189 is proven safe. It is demonstrated to grow new neurons and to grow tissue mass in the hippocampus. It is showing cognitive improvements in humans. It should have a value higher than $4 million. We also have proprietary neural stem cells.

Our company also has some cash and some assets. In China or India they could start using NSI-189 and helping people that could use some help. Stroke, Alzheimer’s, Fronto-Temporal Dementia, TBI, autism are all neurodegenerative diseases. NSI-189 is a neuro-regenerative molecule. It is safe. Perhaps it could be a supplement in less restrictive countries. The more it gets used, the more we will learn what it is good for.

What am I missing here? That management is incompetent?